Market by Component, Deployment Mode, and Country Outlook | Forecast 2023-2030
As per Triton Market Research’s report, the pharmaceutical supply chain management market in Europe is deemed to attain a compound annual growth rate of 8.73% during the forecast period 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries considered in this given region consist of:
•
United Kingdom
•
Germany
•
France
•
Nordic Countries
•
Spain
•
Italy
•
Rest of Europe
In
this region, technology adoption is notably high, driving the consistent
integration of diverse supply chain management software and hardware solutions
within the pharma sector. This trend has led governments to promote cloud
expansion through specific initiatives. In addition, implementing GS1 standards
has accelerated operational speed and automation, resulting in cost reductions.
Considering this escalating technology integration and GS1 implementation, the
pharmaceutical supply chain management market is expected to witness growth
over the projected years.
As per our estimates, France is
expected to progress the fastest in the region’s market during the forecast
period. This
is primarily due to extensive regulatory oversight of the domestic
pharmaceutical sectors, particularly concerning reimbursable drugs, which
account for approximately 30% of total sales.
In
addition, the government is actively working to make medicines more affordable
for end-users. These initiatives may include lowering the prices of drugs and
medicines. Overall, proactive regulatory measures and government initiatives to
enhance affordability are likely to drive significant growth in the medical
sector, thereby promoting the progression of the pharmaceutical supply chain
management market.
Similarly, Italy is investing significantly in digital
medical advances, precision medicine, and personalized treatments. This
indicates an increased demand for effective and reliable supply chain solutions
to support the expansion and distribution needs of the healthcare sector.
Therefore, these investments can drive the expansion of the pharmaceutical
supply chain management market.
Professional services in pharmaceutical supply chain
management include expert consulting, formulating effective strategies,
implementing systems, and providing training. Moreover, the consulting services
include assessing current supply chain processes, identifying areas for
improvement, and creating plans to increase efficiency. These services are
crucial as they ensure streamlined operations, optimized strategies, efficient
systems, well-executed projects, and a knowledgeable workforce, all
contributing to effective and cost-efficient healthcare product distribution.
The market’s growth is determined in
terms of deployment mode and component. Based on component, it is branched
into solution and service. The service segment is further categorized into
professional services and managed services.
The
key companies listed in the market report include Jump
Technologies Inc, Oracle Corporation, Tecsys Inc, McKesson Corporation, and
Manhattan Associates Inc.
McKesson Corporation distributes medications and provides healthcare services. Moreover, its services include distributing pharmaceuticals, medical equipment, health products, etc. They cater to various sectors, such as retail, hospital, and alternate-site pharmacies. McKesson is headquartered in Texas, USA and operates in various regions, including Europe.
Key deliverables of the
report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the pharmaceutical supply chain management market revenue growth
in Europe and its influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the Europe pharmaceutical supply chain management market’s
growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
BUYING IMPACT ANALYSIS
2.5.1. COMPETITIVE
PRICING
2.5.2. INTEGRATION
CAPABILITIES
2.5.3. INVENTORY
MANAGEMENT
2.5.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.5.5. SECURITY
AND DATA PRIVACY
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.7.2. IMPLEMENTATION
OF GS1 STANDARD
2.7.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.7.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.7.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.8. MARKET
CHALLENGES
2.8.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.8.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.8.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.8.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.9. MARKET
OPPORTUNITIES
2.9.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAINS
2.9.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COUNTRY OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1. UNITED
KINGDOM
5.1.1.1. UNITED
KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.2. GERMANY
5.1.2.1. GERMANY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.3. FRANCE
5.1.3.1. FRANCE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.4. ITALY
5.1.4.1. ITALY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.5. SPAIN
5.1.5.1. SPAIN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.6. NORDIC
COUNTRIES
5.1.6.1. NORDIC
COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.1.7. REST
OF EUROPE
5.1.7.1. REST
OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $ MILLION)
TABLE 7: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 & 2030
(IN %)
FIGURE 3: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 & 2030 (IN
%)
FIGURE 4: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 5: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND ANALYTICS,
2023-2030 (IN $ MILLION)
FIGURE 6: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND INVENTORY
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 7: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING,
2023-2030 (IN $ MILLION)
FIGURE 8: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 9: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 & 2030 (IN
%)
FIGURE 10: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 11: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030
(IN $ MILLION)
FIGURE 12: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022 &
2030 (IN %)
FIGURE 13: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $
MILLION)
FIGURE 14: EUROPE PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $ MILLION)
FIGURE 15: EUROPE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022 &
2030 (IN %)
FIGURE 16: UNITED KINGDOM
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: GERMANY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: FRANCE
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: ITALY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: SPAIN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: NORDIC COUNTRIES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE
22: REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN
$ MILLION)